1-4 of 4
Keywords: human embryonic stem cell
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Biochem Soc Trans (2010) 38 (4): 1051–1057.
Published: 26 July 2010
...). In the present review, we provide diverse illustrations of the use of pluripotent stem cells in drug discovery and predictive toxicology, using either human embryonic stem cell lines or iPSC lines. 1 To whom correspondence should be addressed (email mpeschanski@istem.fr ). 11 1 2010 ©...
Biochem Soc Trans (2010) 38 (4): 1058–1061.
Published: 26 July 2010
...Peter Burton; David R. Adams; Achamma Abraham; Robert W. Allcock; Zhong Jiang; Angela McCahill; Jane Gilmour; John McAbney; Nicole M. Kane; George S. Baillie; Fergus R. McKenzie; Andrew H. Baker; Miles D. Houslay; Joanne C. Mountford; Graeme Milligan hESCs (human embryonic stem cells) offer great...
Biochem Soc Trans (2010) 38 (4): 1037–1045.
Published: 26 July 2010
... cardiomyocytes, namely those from hPSCs [human PSCs (pluripotent stem cells)], and place particular emphasis on the pharmacological responses that have been reported. hPSCs comprise hESCs (human embryonic stem cells), derived from the blastocyst stage embryo [ 6 ], and hiPSCs (human induced PSCs) derived...
Biochem Soc Trans (2008) 36 (3): 272–275.
Published: 21 May 2008
.... Thus, if cell therapy should be widely available, it will require an unlimited source of cells to serve as a ‘biological’ insulin pump. At this time, the development of β-cells from hESCs (human embryonic stem cells) has emerged as the most attractive alternative. It is envisioned that ultimate success...